{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:43Z","timestamp":1791413323621,"version":"4.3.3"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DGA-MRIS"},{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00e9 scholarship","doi-asserted-by":"publisher","award":["ANR-ST14-ASTR-0026"],"award-info":[{"award-number":["ANR-ST14-ASTR-0026"]}],"id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.antiviral.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T02:45:41Z","timestamp":1473993941000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Filovirus proteins for antiviral drug discovery: A structure\/function analysis of surface glycoproteins and virus entry"],"prefix":"10.1016","volume":"135","author":[{"given":"Baptiste","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-6305","authenticated-orcid":false,"given":"Thomas","family":"Hoenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.09.001_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cbf.3182","article-title":"Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity","volume":"34","author":"Akpovwa","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.09.001_bib2","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib3","series-title":"C-type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in Cis and in Trans","author":"Alvarez","year":"2002"},{"key":"10.1016\/j.antiviral.2016.09.001_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mam.2007.09.005","article-title":"Ebolavirus and marburgvirus: insight the Filoviridae family","volume":"29","author":"Ascenzi","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.antiviral.2016.09.001_bib5","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1128\/AAC.48.10.3858-3870.2004","article-title":"Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection","volume":"48","author":"Balzarini","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2006.08.018","article-title":"Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage","volume":"358","author":"Barrientos","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/AAC.01407-13","article-title":"Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models","volume":"58","author":"Barton","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.001_bib8","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib9","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel small molecule entry inhibitors of ebola virus","volume":"212","author":"Basu","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.20011500","article-title":"Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses","volume":"195","author":"Bavari","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.09.001_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2016.05.017","article-title":"Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library","volume":"132","author":"Beck","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.001_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1099\/0022-1317-76-2-393","article-title":"The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus","volume":"76","author":"Becker","year":"1995","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2011.07.018","article-title":"Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions","volume":"419","author":"Bhattacharyya","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2010.02.015","article-title":"Ebola virus uses clathrin-mediated endocytosis as an entry pathway","volume":"401","author":"Bhattacharyya","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib15","doi-asserted-by":"crossref","first-page":"e02154","DOI":"10.1128\/mBio.02154-15","article-title":"Host-primed ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2016.09.001_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2011.04.002","article-title":"Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein","volume":"415","author":"Brindley","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.001_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11745-009-3305-7","article-title":"Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes","volume":"44","author":"Cenedella","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.antiviral.2016.09.001_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.09.001_bib21","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1128\/JVI.74.10.4933-4937.2000","article-title":"Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses","volume":"74","author":"Chan","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib22","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of ebola and Marburg virus Entry by G Protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib23","first-page":"565","article-title":"Emerging targets and novel approaches to Ebola virus prophylaxis and treatment","volume":"27","author":"Choi","year":"2013","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"10.1016\/j.antiviral.2016.09.001_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.001_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2014.0068","article-title":"The multiple roles of sGP in Ebola pathogenesis","volume":"28","author":"de La Vega","year":"2015","journal-title":"Viral Immunol."},{"issue":"12","key":"10.1016\/j.antiviral.2016.09.001_bib26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nsmb.2150","article-title":"A\u00a0shared structural solution for neutralizing ebolaviruses","volume":"18","author":"Dias","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib27","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1093\/infdis\/jiv268","article-title":"Shedding of ebola virus surface glycoprotein is a mechanism of self-regulation of cellular cytotoxicity and has a direct effect on virus infectivity","volume":"212","author":"Dolnik","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib28","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","article-title":"Ectodomain shedding of the glycoprotein GP of Ebola virus","volume":"23","author":"Dolnik","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2016.09.001_bib29","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1182\/blood-2006-09-048058","article-title":"The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells","volume":"109","author":"Dominguez-Soto","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2016.09.001_bib30","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in\u00a0vitro but failed to protect against infection and disease in the in\u00a0vivo Guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib31","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"Elshabrawy","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib32","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1128\/JVI.76.10.5266-5270.2002","article-title":"Association of the caveola vesicular system with cellular entry by filoviruses","volume":"76","author":"Empig","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib33","doi-asserted-by":"crossref","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-P\u00e9rez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib34","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cbic.200600223","article-title":"Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus","volume":"7","author":"Falzarano","year":"2006","journal-title":"Chembiochem Eur. J. Chem. Biol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib35","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of protection against ebola virus from chloroquine in mice and hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet Lond. Engl."},{"issue":"Suppl.\u00a015","key":"10.1016\/j.antiviral.2016.09.001_bib37","first-page":"159","article-title":"The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis","author":"Feldmann","year":"1999","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.virol.2008.10.029","article-title":"Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein","volume":"383","author":"Francica","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib39","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein","volume":"6","author":"Francica","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/v7010285","article-title":"Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif","volume":"7","author":"Gallaher","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.09.001_bib41","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/jac\/dku091","article-title":"The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry","volume":"69","author":"Gehring","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2016.09.001_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","article-title":"Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression","volume":"424","author":"Gnirss","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib44","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural insights into the Niemann-Pick C1 (NPC1)-Mediated cholesterol transfer and ebola infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.09.001_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.06.026","article-title":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus","volume":"340","author":"Gramberg","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virol.2007.11.001","article-title":"Interactions of LSECtin and DC-SIGN\/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding","volume":"373","author":"Gramberg","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib47","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/JVI.73.4.3491-3496.1999","article-title":"Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells","volume":"73","author":"Harcourt","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2005.09.018","article-title":"Filovirus assembly and budding","volume":"344","author":"Hartlieb","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib49","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","article-title":"Structural basis for Marburg virus neutralization by a cross-reactive human antibody","volume":"160","author":"Hashiguchi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.09.001_bib50","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.bmcl.2013.07.056","article-title":"C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking","volume":"23","author":"Higgins","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib51","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1093\/infdis\/jiv111","article-title":"Soluble glycoprotein is not required for ebola virus virulence in Guinea pigs","volume":"212","author":"Hoenen","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib52","doi-asserted-by":"crossref","first-page":"e0149651","DOI":"10.1371\/journal.pone.0149651","article-title":"The glycoproteins of all filovirus species use the same host factors for entry into bat and human cells but entry efficiency is species dependent","volume":"11","author":"Hoffmann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.09.001_bib53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/JVI.01278-09","article-title":"The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus","volume":"85","author":"Hunt","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib54","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/JVI.75.3.1576-1580.2001","article-title":"Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies","volume":"75","author":"Ito","year":"2001","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.09.001_bib55","doi-asserted-by":"crossref","first-page":"S897","DOI":"10.1093\/infdis\/jir313","article-title":"sGP serves as a structural protein in Ebola virus infection","volume":"204","author":"Iwasa","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib56","series-title":"FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection","author":"Johansen","year":"2013"},{"key":"10.1016\/j.antiviral.2016.09.001_bib57","first-page":"1481","article-title":"The Role of histidine residues in low-pH-mediated viral membrane fusion","volume":"14","author":"Kampmann","year":"2006","journal-title":"Struct. Lond. Engl."},{"key":"10.1016\/j.antiviral.2016.09.001_bib58","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.001_bib59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In\u00a0vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.09.001_bib60","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib61","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2016.09.001_bib62","doi-asserted-by":"crossref","first-page":"e50316","DOI":"10.1371\/journal.pone.0050316","article-title":"Ebola virus genome plasticity as a marker of its assaging history: a comparison of in\u00a0vitro passaging to non-human primate infection","volume":"7","author":"Kugelman","year":"2012","journal-title":"PLoS one"},{"key":"10.1016\/j.antiviral.2016.09.001_bib63","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib64","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1128\/JVI.03156-14","article-title":"Interaction between TIM-1 and NPC1 is important for cellular entry of ebola virus","volume":"89","author":"Kuroda","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.001_bib66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ml300370k","article-title":"Inhibition of ebola virus infection: identification of Niemann-Pick C1 as the target by optimization of a chemical probe","volume":"4","author":"Lee","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.09.001_bib68","article-title":"The roles of histidines and charged residues as potential triggers of a conformational change in the fusion loop of Ebola virus glycoprotein","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.09.001_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2015.06.018","article-title":"Structure of the L Protein of vesicular stomatitis virus from electron cryomicroscopy","volume":"162","author":"Liang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.09.001_bib70","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/JVI.77.2.1337-1346.2003","article-title":"Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR","volume":"77","author":"Lin","year":"2003","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib71","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/infdis\/jiv030","article-title":"Structural and functional studies on the Marburg virus GP2 fusion loop","volume":"212","author":"Liu","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2016.09.001_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12688\/f1000research.6085.1","article-title":"Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry","volume":"4","author":"Long","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.antiviral.2016.09.001_bib74","doi-asserted-by":"crossref","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","article-title":"A\u00a0systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.09.001_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2006.06.041","article-title":"Characterization of Marburg virus glycoprotein in viral entry","volume":"358","author":"Manicassamy","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005373","article-title":"Induction of cell-cell fusion by Ebola virus glycoprotein: low pH is not a trigger","volume":"12","author":"Markosyan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JVI.02265-13","article-title":"Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus","volume":"88","author":"Maruyama","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib79","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib80","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1086\/520607","article-title":"Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR","volume":"196","author":"Marzi","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib81","doi-asserted-by":"crossref","first-page":"e1923","DOI":"10.1371\/journal.pntd.0001923","article-title":"Cathepsin B & L are not required for ebola virus replication","volume":"6","author":"Marzi","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib82","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.02021-09","article-title":"Different potential of C-type lectin-mediated entry between Marburg virus strains","volume":"84","author":"Matsuno","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2010.10.136","article-title":"C-type lectins do not act as functional receptors for filovirus entry into cells","volume":"403","author":"Matsuno","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.09.001_bib84","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A\u00a0new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib85","doi-asserted-by":"crossref","first-page":"e1003677","DOI":"10.1371\/journal.ppat.1003677","article-title":"Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure","volume":"9","author":"Mehedi","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib86","doi-asserted-by":"crossref","unstructured":"Mendoza, EJ., Qiu, X., Kobinger, G.P. Progression of Ebola therapeutics during the 2014-2015 outbreak. Trends Mol. Med. 22, 164\u2013173. doi: http:\/\/dx.doi.org\/10.1016\/j.molmed.2015.12.005.","DOI":"10.1016\/j.molmed.2015.12.005"},{"issue":"2","key":"10.1016\/j.antiviral.2016.09.001_bib87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/infdis\/jiq025","article-title":"High-dose mannose-binding lectin therapy for Ebola virus infection","volume":"203","author":"Michelow","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib88","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.M110.207084","article-title":"Inhibition of Ebola virus entry by a C-peptide targeted to endosomes","volume":"286","author":"Miller","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.09.001_bib89","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola virus entry requires the host-programmed recognition of an intracellular receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2016.09.001_bib90","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1128\/JVI.00136-12","article-title":"Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection","volume":"86","author":"Miller","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib91","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib92","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.01810-14","article-title":"Less is more: ebola virus surface glycoprotein expression levels regulate virus production and infectivity","volume":"89","author":"Mohan","year":"2015","journal-title":"J.\u00a0Virol."},{"issue":"15","key":"10.1016\/j.antiviral.2016.09.001_bib93","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1128\/JVI.01025-13","article-title":"Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry","volume":"87","author":"Moller-Tank","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib94","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.virol.2014.09.009","article-title":"Phosphatidylserine receptors: enhancers of enveloped virus entry and infection","volume":"468\u2013470","author":"Moller-Tank","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460794.2.2.205","article-title":"Filovirus replication and transcription","volume":"2","author":"M\u00fchlberger","year":"2007","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib96","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nchem.2387","article-title":"Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection","volume":"8","author":"Mu\u00f1oz","year":"2016","journal-title":"Nat. Chem."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.09.001_bib97","doi-asserted-by":"crossref","first-page":"S978","DOI":"10.1093\/infdis\/jir334","article-title":"Antibody-dependent enhancement of Marburg virus infection","volume":"204","author":"Nakayama","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib98","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/CVI.00170-10","article-title":"Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies","volume":"17","author":"Nakayama","year":"2010","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"10.1016\/j.antiviral.2016.09.001_bib99","doi-asserted-by":"crossref","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib100","doi-asserted-by":"crossref","first-page":"07","DOI":"10.1128\/mSphere.00007-16","article-title":"A\u00a0single residue in Ebola virus receptor NPC1 influences cellular host range in reptiles","volume":"1","author":"Ndungo","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.antiviral.2016.09.001_bib101","doi-asserted-by":"crossref","first-page":"e1002304","DOI":"10.1371\/journal.ppat.1002304","article-title":"Discovery of an ebolavirus-like filovirus in europe","volume":"7","author":"Negredo","year":"2011","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.antiviral.2016.09.001_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/v8080206","article-title":"Clomiphene and its isomers block ebolavirus particle entry and infection with similar potency: potential therapeutic implications","volume":"8","author":"Nelson","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.09.001_bib103","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.virol.2014.08.019","article-title":"Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1","volume":"468\u2013470","author":"Ng","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11785","article-title":"Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats","volume":"4","author":"Ng","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2016.09.001_bib105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.20344\/amp.5828","article-title":"Ebolavirosis: a 2014 review for clinicians","volume":"27","author":"Nina","year":"2014","journal-title":"Acta M\u00e9dica Port."},{"key":"10.1016\/j.antiviral.2016.09.001_bib106","first-page":"45","article-title":"A\u00a0synthetic serine protease inhibitor, nafamostat mesilate, is a drug potentially applicable to the treatment of ebola virus disease. Tohoku","volume":"237","author":"Nishimura","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.09.001_bib107","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1371\/journal.ppat.0020099","article-title":"Assembly and budding of ebolavirus","volume":"2","author":"Noda","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib108","series-title":"Chemical and Structural Aspects of Ebola Virus Entry Inhibitors","author":"Nyakatura","year":"2015"},{"key":"10.1016\/j.antiviral.2016.09.001_bib109","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O'Hearn","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/v3081501","article-title":"Intracellular events and cell fate in filovirus infection","volume":"3","author":"Olejnik","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.09.001_bib111","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib112","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/JVI.02077-15","article-title":"The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses","volume":"90","author":"P\u00e9cheur","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib113","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1074\/jbc.M706292200","article-title":"A\u00a0novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans","volume":"283","author":"Powlesland","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.09.001_bib114","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1038\/srep03365","article-title":"Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb","volume":"3","author":"Qiu","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2016.09.001_bib115","doi-asserted-by":"crossref","first-page":"138ra81","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2016.09.001_bib116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.001_bib117","doi-asserted-by":"crossref","first-page":"207ra143","DOI":"10.1126\/scitranslmed.3006605","article-title":"mAbs and Ad-vectored IFN-\u03b1 therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"Qiu","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2016.09.001_bib118","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1128\/JVI.02600-10","article-title":"Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry","volume":"85","author":"Radoshitzky","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib119","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/v3091634","article-title":"Filoviral immune evasion mechanisms","volume":"3","author":"Ramanan","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.09.001_bib120","doi-asserted-by":"crossref","unstructured":"Ray, R.B., Basu, A., Steele, R., Beyene, A., McHowat, J., Meyer, K., Ghosh, A.K., Ray, R. Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology 321(2):181\u2013188.","DOI":"10.1016\/j.virol.2003.12.014"},{"key":"10.1016\/j.antiviral.2016.09.001_bib121","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1128\/JVI.00784-09","article-title":"Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins","volume":"83","author":"Reynard","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40588-015-0021-3","article-title":"Ebola virus entry into host cells: identifying therapeutic strategies","volume":"2","author":"Rhein","year":"2015","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.antiviral.2016.09.001_bib123","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1128\/JVI.00100-16","article-title":"Characterization of human and murine T-cell Immunoglobulin Mucin domain 4 (TIM-4) IgV domain residues critical for Ebola virus entry","volume":"90","author":"Rhein","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0005-2760(90)90284-5","article-title":"Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease","volume":"1043","author":"Rodriguez-Lafrasse","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2016.09.001_bib125","doi-asserted-by":"crossref","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.001_bib126","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.09.001_bib127","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/JVI.01621-12","article-title":"Filoviruses utilize glycosaminoglycans for their attachment to target cells","volume":"87","author":"Salvador","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib128","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1086\/520597","article-title":"Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity","volume":"196","author":"Sanchez","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.09.001_bib130","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib132","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1386-6532(00)00139-6","article-title":"The anti-HIV-1 activity of chloroquine","volume":"20","author":"Savarino","year":"2001","journal-title":"J.\u00a0Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib133","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.09.010","article-title":"Lipids in innate antiviral defense","volume":"14","author":"Schoggins","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.09.001_bib134","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.0807578106","article-title":"Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins","volume":"106","author":"Schornberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib135","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib136","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/mol.110.064261","article-title":"A\u00a0small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells","volume":"78","author":"Shah","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib137","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1128\/JVI.01157-06","article-title":"Tyro3 family-mediated cell entry of Ebola and Marburg viruses","volume":"80","author":"Shimojima","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib138","doi-asserted-by":"crossref","first-page":"e56265","DOI":"10.1371\/journal.pone.0056265","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"Shoemaker","year":"2013","journal-title":"PloS One"},{"issue":"92","key":"10.1016\/j.antiviral.2016.09.001_bib139","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1055\/s-0028-1106144","article-title":"[On the etiology of an unknown human infection originating from monkeys]","volume":"1946","author":"Siegert","year":"1967","journal-title":"Dtsch. Med. Wochenschr"},{"key":"10.1016\/j.antiviral.2016.09.001_bib140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4614-7651-1_5","article-title":"Filovirus entry","volume":"790","author":"Simmons","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib142","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/jvi.76.5.2518-2528.2002","article-title":"Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence","volume":"76","author":"Simmons","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib143","doi-asserted-by":"crossref","first-page":"17339","DOI":"10.1073\/pnas.1010026107","article-title":"Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses","volume":"107","author":"St Vincent","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib144","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fmicb.2012.00034","article-title":"Filovirus tropism: cellular molecules for viral entry","volume":"3","author":"Takada","year":"2012","journal-title":"Front. Microbiol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib145","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib146","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1128\/JVI.77.13.7539-7544.2003","article-title":"Antibody-dependent enhancement of Ebola virus infection","volume":"77","author":"Takada","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib147","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry","volume":"78","author":"Takada","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib148","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0966-842X(01)02201-6","article-title":"The pathogenesis of Ebola hemorrhagic fever","volume":"9","author":"Takada","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib149","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2000.0601","article-title":"Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry","volume":"278","author":"Takada","year":"2000","journal-title":"Virology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib150","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/infdis\/jiu681","article-title":"An improved reverse genetics system to overcome cell-type-dependent ebola virus genome plasticity","volume":"212","author":"Tsuda","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib151","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/acsinfecdis.5b00130","article-title":"Cysteine cathepsin inhibitors as anti-Ebola agents","volume":"2","author":"van der Linden","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.09.001_bib152","doi-asserted-by":"crossref","first-page":"S941","DOI":"10.1093\/infdis\/jir321","article-title":"Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of Guinea pigs","volume":"204","author":"Volchkova","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib153","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/viro.1999.0034","article-title":"Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus","volume":"265","author":"Volchkova","year":"1999","journal-title":"Virology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.001_bib154","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/infdis\/jiv309","article-title":"RNA editing of the GP gene of ebola virus is an important pathogenicity factor","volume":"212","author":"Volchkova","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.001_bib155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.001_bib156","doi-asserted-by":"crossref","unstructured":"Volchkov, V.E., Volchkova, V.A., Str\u00f6her, U., Becker, S., Dolnik, O., Cieplik, M., Garten, W., Klenk, H.D., Feldmann, H. Proteolytic processing of Marburg virus glycoprotein. Virology 268(1):1\u20136. doi:http:\/\/dx.doi.org\/10.1006\/viro.1999.0110.","DOI":"10.1006\/viro.1999.0110"},{"key":"10.1016\/j.antiviral.2016.09.001_bib157","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1126\/science.1057269","article-title":"Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity","volume":"291","author":"Volchkov","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.09.001_bib158","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","article-title":"Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib159","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.09.001_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.11.003","article-title":"Teicoplanin inhibits Ebola pseudovirus infection in cell culture","volume":"125","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.001_bib161","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2764","article-title":"A\u00a0new player in the puzzle of filovirus entry","volume":"10","author":"White","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib162","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A\u00a0broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.001_bib163","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pro.2026","article-title":"Bidentate and tridentate metal-ion coordination states within ternary complexes of RB69 DNA polymerase","volume":"21","author":"Xia","year":"2012","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.antiviral.2016.09.001_bib164","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s13238-015-0220-y","article-title":"TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope","volume":"6","author":"Yuan","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2016.09.001_bib165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coviro.2016.01.006","article-title":"Antibody therapeutics for Ebola virus disease","volume":"17","author":"Zeitlin","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.001_bib166","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/1873-3468.12089","article-title":"Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions","volume":"590","author":"Zhao","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2016.09.001_bib167","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:06:57Z","timestamp":1601086017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":165,"alternative-id":["S0166354216304077"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Filovirus proteins for antiviral drug discovery: A structure\/function analysis of surface glycoproteins and virus entry","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}